Product Information
VELPHORO 500 MG CHEWABLE TAB is a brand product labeled by Fresenius Medical Care Renal Therapies Group, LLC, priced at $17.1055 per EA under NDC 49230064551. Its NADAC has been published 629 times since Sep 17, 2014.
FDA first approved this application on Nov 27, 2013.
Strength
500 mg/1
NDC
49230064551
Classification
Brand
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
FERRIC OXYHYDROXIDEApproval Type
New Drug (NDA)
FDA Application
NDA205109FDA Approved
11/27/2013
On Market Since
11/27/2013
Pharmacological Classes
Price Statistics
The NADAC for VELPHORO 500 MG CHEWABLE TAB has been published 629 times since Sep 17, 2014, and over the history we have for it it has risen 87.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.1055 per EA |
|---|---|
| All-time high | $17.1422 (Aug 14, 2024) |
| All-time low | $9.1377 (Sep 17, 2014) |
| 52-week high | $17.1179 |
| 52-week low | $17.1012 |
| Median price | $13.9928 |
| Average price | $13.9036 |
| Largest weekly change | +5.0% (Jan 10, 2018) |
| Weeks tracked | 629 |
| Tracking since | Sep 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sucroferric oxyhydroxide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Medical Care Renal Therapies Group, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sucroferric oxyhydroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VELPHORO 500 MG CHEWABLE TAB?
The current National Average Drug Acquisition Cost (NADAC) for VELPHORO 500 MG CHEWABLE TAB, manufactured by Fresenius Medical Care Renal Therapies Group, LLC, is $17.1055 per EA (NDC 49230064551), effective Sep 30, 2026.
How has the price of VELPHORO 500 MG CHEWABLE TAB changed over time?
Over the history we have for it, the NADAC for VELPHORO 500 MG CHEWABLE TAB has risen 87.2%. It has been tracked across 629 weekly CMS publications since Sep 17, 2014.
What are the highest and lowest recorded NADAC prices for VELPHORO 500 MG CHEWABLE TAB?
Since Sep 17, 2014, the NADAC for VELPHORO 500 MG CHEWABLE TAB has ranged from a low of $9.1377 (Sep 17, 2014) to a high of $17.1422 (Aug 14, 2024), with a median of $13.9928 per EA.
Are there cheaper alternatives to VELPHORO 500 MG CHEWABLE TAB?
No other NADAC-published product currently shares the active ingredient and strength of VELPHORO 500 MG CHEWABLE TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VELPHORO 500 MG CHEWABLE TAB?
VELPHORO 500 MG CHEWABLE TAB (NDC 49230064551) is labeled by Fresenius Medical Care Renal Therapies Group, LLC, and CMS classifies it as a brand product.